Is Astal Laboratories Ltd (512600) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Astal Laboratories Ltd is a below average quality company .

Is Astal Laboratories Ltd (512600) undervalued or overvalued?

The key valuation ratios of Astal Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Astal Laboratories Ltd (512600) share price return in the past 10 years?

Astal Laboratories Ltd share price has appreciated 11.8% annually (CAGR) over the past ten years.

Is Astal Laboratories Ltd (512600) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Astal Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Astal Laboratories Ltd (512600)?

Company share prices are keep on changing according to the market conditions. The current trading price of Astal Laboratories Ltd (512600) on 13-Apr-2026 16:59:59 at 16:59 is 67.27.

What is the P/E ratio of Astal Laboratories?

The latest standalone P/E ratio of Astal Laboratories as of 13-Apr-2026 is 29.05.

What is the P/B ratio of Astal Laboratories Ltd (512600)?

The latest standalone P/B ratio of Astal Laboratories Ltd (512600) as of 13-Apr-2026 is 3.53.

What is the 52-week high and low of Astal Laboratories Ltd (512600)?

The 52-week high of Astal Laboratories Ltd (512600) is Rs. 103.20 and the 52-week low is Rs. 64.05.

Astal Laboratories Ltd (512600) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Astal Laboratories Ltd (512600)
Brand: Astal Laboratories

Astal Laboratories Ltd (512600) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Astal Laboratories Ltd (512600)

BSE: 512600 NSE:

Key Metrics

Market Cap

₹284 Cr.

P/E Ratio

29.05

Price to Book (P/B)

3.53

Price to Sales (P/S)

2.05

EV/EBITDA

19.55

Return on Capital Employed (ROCE)

34.78%

Current Price

₹67.3

Return on Equity (ROE)

32.12%

Return on Assets (ROA)

17.86%

Operating Profit Margin

19.9%

Net Profit Margin

13.9%

Gross Profit Margin

19%

Book Value per Share

₹19.1

Sales Growth (YoY)

171.59%

Sales Growth (3 Years)

NA%

Operating Profit Growth (1 Year)

1051.35%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

1044.87%

52-Week Low / High

₹64 / 103

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

18.19%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1

Astal Laboratories Ltd revenue growth is 171.6% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.

Q.1

Promoters hold 18.19% of the Astal Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1

Astal Laboratories Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.

Q.1

Astal Laboratories Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1

Over the last 9 years, the stock has delivered a CAGR of 11.8% based on the current price.

DeciZen - make an informed investing decision on Astal Laboratories

Based on:

Data

Overall Rating ⓘ
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation ⓘ

3. Price Trend

Astal Laboratories stock performance

Key Ratios

Is Astal Laboratories Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0.4%	0.2%	-0.1%	-1.4%	-0.5%	0.2%	-0.3%	0.6%	7.6%	34.8%	-
Value Creation Index ⓘ	-1.0	-1.0	-1.0	-1.1	-1.0	-1.0	-1.0	-1.0	-0.5	1.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0	3.4	23.7	64.2	139
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	589.5%	171.6%	-
Adj EPS ⓘ	0.1	0	-0	-0.2	-0.1	0	-0	0	0.8	9.1	2.3
YoY Gr.	-	-80%	-300%	NA	NA	NA	-250%	NA	1900%	1035%	-
BVPS (₹) ⓘ	13.3	13.3	13.3	13	13	13	13	13	23.7	32.8	19.1
Adj Net Profit ⓘ	0	0	-0	-0.1	-0	0	-0	0	0.8	8.9	10
Cash Flow from Ops. ⓘ	-0.2	-0.3	-0.3	-0.3	-0.2	-0.2	-0.3	-1.4	-5.6	-12.5	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	-0.1	-1.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	171.6%
Adj EPS ⓘ	78.2%	NA	NA	1035%
BVPSⓘ	10.6%	20.4%	36.3%	38.3%
Share Price	11.8%	50.4%	29.4%	-22.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	0.3	0.1	-0.1	-1.6	-0.5	0.1	-0.3	0.3	5.5	30.1	8.9
Op. Profit Mgn % ⓘ	0	0	0	0	0	0	0	-4.1	4.7	19.9	10.7
Net Profit Mgn % ⓘ	0	0	0	0	0	0	0	0.5	3.3	13.9	7.1
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0.4	-
Working Cap Days ⓘ	0	0	0	0	0	0	0	799	306	227	95
Cash Conv. Cycle ⓘ	0	0	0	0	0	0	0	-30	31	87	36

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	2.3	-
TTM Sales (₹ Cr.)	139	-
BVPS (₹) ⓘ	19.1	-
Reserves (₹ Cr.) ⓘ	38	-
P/BV ⓘ	3.53	-
PE ⓘ	29.05	-

From the Market
52 Week Low / High (₹)	64.05 / 103.20
All Time Low / High (₹)	4.05 / 131.70
Market Cap (₹ Cr.)	284
Equity (₹ Cr.)	42.2
Face Value (₹)	10
Industry PE ⓘ	41.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Astal Laboratories - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	0	0	0	0	0	0	3	24	64
Operating Expenses ⓘ +	0	0	0	0	0	0	0	4	23	51
Manufacturing Costs	0	0	0	0	0	0	0	0	0	1
Material Costs	0	0	0	0	0	0	0	3	21	48
Employee Cost	0	0	0	0	0	0	0	0	0	1
Other Costs ⓘ	0	0	0	0	0	0	0	0	1	2
Operating Profit ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	1	13
Operating Profit Margin (%)	-	-	-	-	-	-	-	-4.1%	4.7%	19.9%
Other Income ⓘ +	0	0	0	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	1
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0	0	-0	-0	-0	0	-0	0	1	12
Tax ⓘ	0	0	0	0	0	0	0	0	0	3
Profit After Tax	0	0	-0	-0	-0	0	-0	0	1	9
PAT Margin (%)	-	-	-	-	-	-	-	0.5%	3.3%	13.9%
Adjusted EPS (₹)	0.0	0.0	-0.0	-0.2	-0.1	0.0	-0.0	0.0	0.8	9.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	5	5	5	5	5	5	5	5	23	32
Share Capital ⓘ	4	4	4	4	4	4	4	4	10	10
Reserves ⓘ	1	1	1	1	1	1	1	1	13	22
Debt +	0	0	0	0	0	0	0	0	0	13
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	13
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	0	0	0	0	4	12	11
Others Liabilities ⓘ	0	0	0	0	0	0	0	1	2	7
Total Liabilities ⓘ	5	5	5	5	5	5	5	10	37	63
Fixed Assets
Net Fixed Assets ⓘ +	0	0	0	0	0	0	0	0	1	11
Gross Block	0	0	0	0	0	0	0	0	1	12
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0	0	0	0	0	0	0	0	1	15
Trade Receivables	0	0	0	0	0	0	0	3	16	28
Cash Equivalents	0	0	0	0	0	0	0	0	6	2
Others Assets ⓘ	5	5	5	5	5	5	5	7	13	8
Total Assets ⓘ	5	5	5	5	5	5	5	10	37	63

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0	-0	-0	-0	-0	-0	-0	-1	-6	-13
PBT ⓘ	0	0	-0	-0	-0	0	-0	0	1	12
Adjustment ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	0	1
Changes in Working Capital ⓘ	0	-0	0	0	0	-0	-0	-1	-7	-25
Tax Paid ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Cash Flow From Investing Activity ⓘ +	0	0	0	0	0	0	0	2	-6	-8
Capex	-0	0	-0	0	0	0	0	0	-1	-6
Net Investments	0	0	0	0	0	0	0	0	0	-2
Others ⓘ	0	0	0	0	0	0	0	2	-5	0
Cash Flow From Financing Activity ⓘ +	0	0	0	0	0	0	0	0	18	3
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	17	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	-0	-1
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	4
Net Cash Flow ⓘ	0	0	-0	0	0	0	-0	0	6	-17

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.16	0.1	-0.13	-1.57	-0.54	0.12	-0.33	0.32	5.51	32.12
ROCE (%)	0.36	0.2	-0.09	-1.44	-0.54	0.16	-0.33	0.62	7.62	34.78
Asset Turnover Ratio	0	0	0	0	0	0	0	0.45	1.02	1.29
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-6	-1.44
Working Capital Days
Receivable Days	0	0	0	0	0	0	0	337	146	124
Inventory Days	0	0	0	0	0	0	0	0	16	45
Payable Days	0	0	0	0	0	0	0	413	131	85

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Astal Laboratories Ltd FAQs

The current trading price of Astal Laboratories on 13-Apr-2026 16:59 is ₹67.27.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Apr-2026 the market cap of Astal Laboratories stood at ₹284.0 Cr

The latest P/E ratio of Astal Laboratories as of 12-Apr-2026 is 29.05.

The latest P/B ratio of Astal Laboratories as of 12-Apr-2026 is 3.53.

The 52-week high of Astal Laboratories is ₹103.2 and the 52-week low is ₹64.05.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Astal Laboratories is ₹139 ( Cr.) .

About Astal Laboratories Ltd

No data to display

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Astal Laboratories Ltd (512600) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Astal Laboratories Share Price